logo-loader
HealthPharma & Biotech
Alliance Pharma PLC

Alliance Pharma launches the UK's only prescription drug for nausea and vomiting during pregnancy

Sold under the brand name Xonvea, the treatment was licensed from Duchesnay of Canada in 2015 and has been prescribed to 33mln women over 40 years

pregnant woman
Around 40% suffer nausea and vomiting during pregnancy

Alliance Pharma plc (LON:APH) has launched the UK’s only prescription treatment for vomiting and nausea during pregnancy.

Sold under the brand name Xonvea, Diclectin was licensed from Duchesnay of Canada in 2015 and has been prescribed to 33mln women over 40 years. Marketing approval from the Medicines and Healthcare products Regulatory Agency took longer than anticipated but was granted over the summer.

Nausea and vomiting are the most common medical condition during pregnancy and affects around 40% of women.

Milestone

Professor Catherine Nelson-Piercy, a consultant obstetric physician, welcomed the launch of Xonvea, saying: “This delayed release formulation of doxylamine and pyridoxine has been used in millions of pregnant women worldwide.” 

“Primary and secondary care doctors caring for pregnant women in the UK are now able to prescribe Xonvea, affording women in the UK a licensed option when it comes to managing this often debilitating condition.”

Alliance chief executive Peter Butterfield called the drug launch a “significant milestone” for pregnant women and the company.

“There is no other licensed treatment for nausea and vomiting of pregnancy in the UK so this is excellent news for patients and clinicians as it fulfils a significant unmet medical need," he added.

Quick facts: Alliance Pharma PLC

Price: £0.70

Market: AIM
Market Cap: £363.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Alliance Pharma PLC named herein, including the promotion by the Company of Alliance Pharma PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Total Voting Rights

1 week, 6 days ago

Total Voting Rights

on 08/02/2019

Half Year Trading Update

on 07/17/2019

Total Voting Rights

on 07/01/2019

Directorate Change

on 07/01/2019

Total Voting Rights

on 06/04/2019

2 min read